Marc L. Panoff - 10 Sep 2025 Form 3 Insider Report for LB PHARMACEUTICALS INC

Role
Senior Vice President, Finance
Signature
/s/ Marc Panoff
Issuer symbol
LBRX on Nasdaq
Transactions as of
10 Sep 2025
Net transactions value
$0
Form type
3
Filing time
29 Sep 2025, 20:12:03 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PANOFF MARC L Senior Vice President, Finance C/O LB PHARMACEUTICALS INC, ONE PENNSYLVANIA PLAZA, SUITE 1025, NEW YORK /s/ Marc Panoff 10 Sep 2025 0001304340

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LBRX Common Stock 10,242 10 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LBRX Employee Stock Option (Right to Buy) 10 Sep 2025 Common Stock 3,944 $64.15 Direct F1
holding LBRX Employee Stock Option (Right to Buy) 10 Sep 2025 Common Stock 896 $69.72 Direct F1
holding LBRX Employee Stock Option (Right to Buy) 10 Sep 2025 Common Stock 1,255 $69.72 Direct F1
holding LBRX Employee Stock Option (Right to Buy) 10 Sep 2025 Common Stock 14,343 $41.84 Direct F2
holding LBRX Employee Stock Option (Right to Buy) 10 Sep 2025 Common Stock 7,171 $41.84 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 One fourth (1/4) of the shares subject to the option award vested on August 25, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F3 One fourth (1/4) of the shares subject to the option award vested on June 28, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.